Financhill
Back

Vertex Pharmaceuticals Vs. Docusign Industry Stock Comparison

Sell
48

VRTX
Vertex Pharmaceuticals

Last Price:
$468.80
Seasonality Move:
3.1%
Sell
36

DOCU
Docusign

Last Price:
$73.53
Seasonality Move:
-3.48%
Sell
48
Vertex Pharmaceuticals (VRTX) is a Sell

Is Vertex Pharmaceuticals a Buy, Sell or Hold?

  • The current Vertex Pharmaceuticals [VRTX] share price is $468.85. The Score for VRTX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • VRTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
36
Docusign (DOCU) is a Sell

Is Docusign a Buy, Sell or Hold?

  • The current Docusign [DOCU] share price is $73.55. The Score for DOCU is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • DOCU is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

VRTX Stock Price Chart

What is Vertex Pharmaceuticals's stock price today?

  • The Vertex Pharmaceuticals share price today is $468.85
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VRTX is experiencing selling pressure, which indicates risk of future bearish movement.

DOCU Stock Price Chart

What is Docusign's stock price today?

  • The Docusign share price today is $73.55
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DOCU is experiencing selling pressure, which indicates risk of future bearish movement.

VRTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 105.32 Buy
Relative Strength Index (14 RSI): 58.87 Buy
Chaikin Money Flow: -740278 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (442.69 - 463.99) Buy
Bollinger Bands (100): (445.06 - 495.08) Sell

DOCU Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 16.96 Buy
Relative Strength Index (14 RSI): 38.8 Sell
Chaikin Money Flow: -2618383 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (73.36 - 80.56) Sell
Bollinger Bands (100): (75.92 - 87.1) Sell

VRTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 465.24 Buy
20-day SMA: 454.46 Buy
50-day SMA: 451.19 Buy
200-day SMA: 463.16 Buy
8-day EMA: 300.22 Buy
20-day EMA: 156.21 Buy
50-day EMA: 70.01 Buy
200-day EMA: 18.56 Buy

DOCU Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 77.33 Sell
20-day SMA: 76.2 Sell
50-day SMA: 81.85 Sell
200-day SMA: 81.51 Sell
8-day EMA: 48.39 Buy
20-day EMA: 25.29 Buy
50-day EMA: 11.35 Buy
200-day EMA: 3.01 Buy

Vertex Pharmaceuticals Earnings Growth & VRTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.47 per share, an increase next quarter of $0.38 per share, an increase this year of $17.51 per share, and an increase next year of $2.62 per share.

Docusign Earnings Growth & DOCU Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.03 per share, an increase next quarter of $0.05 per share, an increase this year of $0.66 per share, and an increase next year of $0.03 per share.

Vertex Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Docusign Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):